Yamada M, Hearse D J, Curtis M J
Cardiovascular Research, Rayne Institute, St. Thomas' Hospital, London, UK.
Circ Res. 1990 Nov;67(5):1211-24. doi: 10.1161/01.res.67.5.1211.
We have examined the pathophysiological role of readmission of oxygen (and hence production of oxygen-derived free radicals) in the initiation of reperfusion-induced arrhythmias by separating, on a temporal basis, readmission flow from readmission of oxygen. Isolated rat hearts (n = 12/group) were subjected to 10 minutes of regional ischemia and 10 minutes of reperfusion. In controls reperfused with oxygenated solution (Po2 greater than 600 mm Hg), 92% of hearts developed ventricular fibrillation (VF) during the first 20 seconds of reperfusion, whereas in hearts reperfused with hypoxic solution (Po2 9.3-12.2 mm Hg), the incidence of VF was only 17% (p less than 0.05). Subsequent readmission of control solution (Po2 greater than 600 mm Hg) to the latter group led, within 20 seconds, to the appearance of VF in seven of the 10 hearts (70%) that had not previously fibrillated. To examine whether hypoxic reperfusion had prevented VF or merely delayed its onset, the studies were repeated in separate groups of hearts with the duration of hypoxic reperfusion extended to 5 minutes. In addition, to examine the partial pressure dependence of the relation, the Po2 in the reperfusion solution was set at one of five different levels: greater than 600, 150-192.7, 69-85.6, 9.2-14.8, or 0.0 mm Hg. It was found that hypoxia merely delayed VF onset by 20-40 seconds and did not significantly reduce the incidence of VF, which was 83%, 92%, 67%, 58%, and 58%, respectively. This indicated that readmission of oxygen is unnecessary for the initiation of VF during reperfusion. The hearts that reverted to sinus rhythm during the ensuing 5 minutes (n = 8, 4, 5, 9, and 8, respectively) were used to assess the arrhythmogenic consequences of readmission of oxygen. When control solution (Po2 greater than 600 mm Hg) was readmitted, new episodes of VF were elicited within 20 seconds in a manner that was inversely proportional to the preceding Po2 (p less than 0.05), the incidence of new episodes of VF being 0%, 0%, 40%, 67%, and 86%, respectively. The arrhythmogenic effect of readmission of oxygen was not the result of a sudden increase in heart rate, because a similar arrhythmogenic effect of readmission of oxygen was seen in separate groups of hearts that were paced (350 beats/min) throughout hypoxia and readmission of oxygen. In conclusion, readmission of flow and readmission of oxygen are independent determinants of reperfusion-induced arrhythmias.(ABSTRACT TRUNCATED AT 400 WORDS)
我们通过在时间上分离氧的再灌注(以及由此产生的氧衍生自由基)与再灌注诱导心律失常起始过程中的血流再灌注,研究了氧再灌注(以及由此产生的氧衍生自由基)在再灌注诱导心律失常起始中的病理生理作用。将离体大鼠心脏(每组n = 12)进行10分钟的局部缺血和10分钟的再灌注。在用含氧溶液(Po2大于600 mmHg)再灌注的对照组中,92%的心脏在再灌注的前20秒内发生室颤(VF),而在用低氧溶液(Po2为9.3 - 12.2 mmHg)再灌注的心脏中,VF的发生率仅为17%(p小于0.05)。随后将对照组溶液(Po2大于600 mmHg)重新灌注到后一组,在20秒内,10个先前未发生颤动的心脏中有7个(70%)出现了VF。为了研究低氧再灌注是预防了VF还是仅仅延迟了其发作,在另一组心脏中重复进行了研究,将低氧再灌注的持续时间延长至5分钟。此外,为了研究该关系的分压依赖性,将再灌注溶液中的Po2设定为五个不同水平之一:大于600、150 - 192.7、69 - 85.6、9.2 - 14.8或0.0 mmHg。发现低氧仅将VF发作延迟了20 - 40秒,并没有显著降低VF的发生率,分别为83%、92%、67%、58%和58%。这表明在再灌注期间,氧的再灌注对于VF的起始并非必要。在随后5分钟内恢复窦性心律的心脏(分别为n = 8、4、5、9和8)被用于评估氧再灌注的致心律失常后果。当重新灌注对照溶液(Po2大于600 mmHg)时,在20秒内引发了新的VF发作,其方式与先前的Po2成反比(p小于0.05),新的VF发作发生率分别为0%、0%、40%、67%和86%。氧再灌注的致心律失常作用不是心率突然增加的结果,因为在整个低氧和氧再灌注过程中以350次/分钟起搏的另一组心脏中也观察到了类似的氧再灌注致心律失常作用。总之,血流再灌注和氧再灌注是再灌注诱导心律失常的独立决定因素。(摘要截短至400字)